News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,241 Results
Type
Article (88742)
Company Profile (816)
Press Release (793661)
Multimedia
Podcasts (236)
Webinars (35)
Section
Business (233574)
Career Advice (4162)
Deals (39981)
Drug Delivery (177)
Drug Development (91686)
Employer Resources (207)
FDA (18550)
Job Trends (17484)
News (398694)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
Adcomms (40)
Allergies (192)
Alliances (56989)
ALS (234)
Alzheimer's disease (1962)
Antibody-drug conjugate (ADC) (548)
Approvals (18881)
Artificial intelligence (858)
Autoimmune disease (350)
Automation (63)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (247)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (84)
Breast cancer (835)
Cancer (6518)
Cardiovascular disease (548)
Career advice (3597)
Career pathing (52)
CAR-T (380)
CDC (76)
Celiac Disease (3)
Cell therapy (1060)
Cervical cancer (53)
Clinical research (78888)
Collaboration (2341)
Company closure (8)
Compensation (1497)
Complete response letters (105)
COVID-19 (3039)
CRISPR (123)
C-suite (1263)
Cystic fibrosis (166)
Data (8573)
Decentralized trials (3)
Denatured (90)
Depression (192)
Dermatology (96)
Diabetes (665)
Diagnostics (7582)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (419)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (315)
Earnings (102475)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138448)
Executive appointments (1186)
FDA (22579)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1916)
Gene editing (269)
Generative AI (90)
Gene therapy (845)
GLP-1 (1262)
Government (5556)
Grass and pollen (8)
Guidances (419)
Healthcare (21247)
HIV (92)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (114)
Immunology and inflammation (351)
Immuno-oncology (114)
Indications (201)
Infectious disease (3433)
Inflammatory bowel disease (241)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (314)
Interviews (821)
IPO (17997)
IRA (61)
Job creations (5208)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (120)
Layoffs (685)
Leadership (53)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (868)
Lymphoma (460)
Machine learning (65)
Management (66)
Manufacturing (1207)
MASH (221)
Medical device (15263)
Medtech (15412)
Mergers & acquisitions (23264)
Metabolic disorders (1763)
mRNA (263)
Multiple sclerosis (203)
NASH (24)
Neurodegenerative disease (499)
Neuropsychiatric disorders (126)
Neuroscience (3687)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5141)
Now hiring (80)
Obesity (845)
Opinion (373)
Ovarian cancer (242)
Pain (281)
Pancreatic cancer (343)
Parkinson's disease (412)
Partnered (39)
Patents (645)
Patient recruitment (734)
Peanut (69)
People (67930)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24383)
Phase 2 (34266)
Phase 3 (25769)
Pipeline (9581)
Policy (396)
Postmarket research (3559)
Preclinical (10957)
Press Release (72)
Prostate cancer (342)
Psychedelics (68)
Radiopharmaceuticals (370)
Rare diseases (1243)
Real estate (7462)
Recruiting (81)
Regulatory (30324)
Reports (77)
Research institute (2768)
Resumes & cover letters (654)
Rett syndrome (40)
RNA editing (29)
RSV (98)
Schizophrenia (194)
Series A (324)
Series B (232)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4370)
State (2)
Stomach cancer (21)
Supply chain (144)
Tariffs (104)
The Weekly (143)
Vaccines (1299)
Venture capital (131)
Weight loss (578)
Women's health (138)
Worklife (24)
Date
Today (89)
Last 7 days (779)
Last 30 days (3476)
Last 365 days (33127)
2026 (15602)
2025 (33220)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (397)
Arkansas (16)
Asia (52249)
Australia (9187)
California (14263)
Canada (3983)
China (1546)
Colorado (610)
Connecticut (634)
Delaware (440)
Europe (120483)
Florida (2116)
Georgia (465)
Hawaii (4)
Idaho (70)
Illinois (1234)
India (102)
Indiana (659)
Iowa (25)
Japan (583)
Kansas (143)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1734)
Massachusetts (10422)
Michigan (421)
Minnesota (795)
Mississippi (7)
Missouri (163)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3781)
New Mexico (35)
New York (3751)
North Carolina (1923)
North Dakota (11)
Northern California (7079)
Ohio (442)
Oklahoma (26)
Oregon (55)
Pennsylvania (2819)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5596)
Tennessee (225)
Texas (2318)
United States (51022)
Utah (425)
Vermont (1)
Virginia (362)
Washington D.C. (89)
Washington State (1174)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 883,241 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Merck continues New Jersey cuts, laying off 88 in Rahway
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
June 8, 2026
·
57 min read
·
BioSpace Editorial Staff
Obesity
Lilly and Novo face off at ADA 2026 as others seek to compete in obesity
The American Diabetes Association’s annual congress will feature a superstar lineup, including weight loss giants Eli Lilly and Novo Nordisk. But several scrappy biotechs will also present obesity candidates with the potential to match—if not outperform—their deep-pocketed competitors.
June 5, 2026
·
8 min read
·
Tristan Manalac
Sickle cell disease
Fulcrum lays off 85% of staff after dropping asset, leaving 9 employees
After discontinuing development of its lead asset, Fulcrum Therapeutics has provided more details on its restructure, with 48 of 57 employees headed out the door.
June 5, 2026
·
2 min read
·
Tristan Manalac
Opinion
The next FDA commissioner must be a champion for gene therapies
The FDA must provide consistent and predictable regulatory frameworks if the U.S. is to maintain its leadership in gene therapy, one of the most consequential therapeutic fields of our generation.
June 5, 2026
·
4 min read
·
Erik Paulsen
Press Releases
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi
June 5, 2026
·
2 min read
Press Releases
Mezzion Pharma Completes FUEL-2 Phase 3 Regulatory Milestone
June 5, 2026
·
2 min read
Press Releases
Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
June 5, 2026
·
2 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2026
June 5, 2026
·
2 min read
Press Releases
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
June 5, 2026
·
4 min read
Press Releases
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson’s Disease
June 5, 2026
·
10 min read
1 of 88,325
Next
